Evidence map›Paper›PMID 22851636›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2012

Age effects on serotonin receptor 1B as assessed by PET.

David Matuskey, Brian Pittman, Beata Planeta-Wilson, Espen Walderhaug, Shannan Henry, Jean-Dominique Gallezot, Nabeel Nabulsi, Yu-Shin Ding, Zubin Bhagwagar, Robert Malison and 2 more

Abstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Trajectories of late-life depression: insights from molecular imaging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. GFrontiers in aging neuroscience · 2019
    Review
  10. Age-Related Change in 5-HTJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. The serotonergic system and cognitive function.Translational neuroscience · 2016
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David MatuskeyDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06520, USA. david.matuskey@yale.edu
Brian Pittman
Beata Planeta-Wilson
Espen Walderhaug
Shannan Henry
Jean-Dominique Gallezot
Nabeel Nabulsi
Yu-Shin Ding
Zubin Bhagwagar
Robert Malison
Richard E Carson
Alexander Neumeister

Funding

Kappa Opioid Receptor Imaging in PTSDR21MH096105 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUMEISTER, ALEXANDER · 2012 to 2014
$746k
Serotonin 1B Receptor Imaging in Major Depressive DisorderR21MH081103 · NIMH · YALE UNIVERSITY · PI NEUMEISTER, ALEXANDER · 2009 to 2010
$413k
Serotonin 1B Receptor Imaging in PTSD with and without Co-morbid DepressionR21MH085627 · NIMH · YALE UNIVERSITY · PI NEUMEISTER, ALEXANDER · 2009 to 2010
$411k
Serotonin 1B Receptor Imaging in Pathological Gambling and Alcohol DependenceR21AA018329 · NIAAA · YALE UNIVERSITY · PI NEUMEISTER, ALEXANDER · 2009 to 2010
$398k
NIAAA NIH HHS R21 AA018329NIMH NIH HHS R21 MH081103NIMH NIH HHS R21 MH085627NIMH NIH HHS R21 MH096105
6 · The paper itself

Abstract

unlabelledPrevious imaging studies have suggested that there is an age-related decline in brain serotonin (5-hydroxytryptamine) measures in healthy subjects. This paper addresses whether the availability of 5-hydroxytryptamine receptor 1B (5-HT(1B)) is seen to decrease with aging via PET imaging.

methodsForty-eight healthy control subjects (mean age ± SD, 30 ± 10 y; age range, 18-61 y; 33 men, 15 women) underwent (11)C-P943 scanning on a high-resolution PET tomograph. Regions were examined with and without gray matter masking, the latter in an attempt to control for age-related gray matter atrophy on nondisplaceable binding potential (BP(ND)) as determined by a validated multilinear reference tissue model.

results5-HT(1B) BP(ND) decreased in the cortex at an average rate of 8% per decade without and 9% with gray matter masking. A negative association with age was also observed in all individual cortical regions. Differences in the putamen and pallidum (positive association) were significant after adjustment for multiple comparisons. No sex- or race-related effects on 5-HT(1B) BP(ND) were found in any regions.

conclusionThese findings indicate that age is a relevant factor for 5-HT(1B) in the cortex of healthy adults.

Indexed as

Positron-Emission TomographyAdolescentAdultAgingCarbon RadioisotopesCerebral CortexFemaleHumansLigandsMaleMiddle AgedPiperazinesPyrrolidinonesReceptor, Serotonin, 5-HT1BSubstrate SpecificityYoung Adult1-(4-(2-methoxyisopropyl)phenyl)-3-(2-(4-methylpiperazin-1-yl)benzyl)pyrrolidin-2-oneCarbon RadioisotopesLigandsPiperazinesPyrrolidinonesReceptor, Serotonin, 5-HT1B

Identifiers

PMID22851636
PMCPMC3690814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.